Discontinuation report JAMP-RIZATRIPTAN IR

Last updated on 2022-09-09 History
Report ID 168998
Drug Identification Number 02429241
Brand name JAMP-RIZATRIPTAN IR
Common or Proper name Rizatriptan Benzoate Tablets
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1x6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-09-07
Remaining supply date 2021-08-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-09-09 French Compare
v1 2022-09-09 English Compare

Showing 1 to 2 of 2